Daniel Lochner - Dec 1, 2022 Form 4 Insider Report for Oyster Point Pharma, Inc. (OYST)

Signature
/s/ Brandon Fenn, Attorney-in-Fact
Stock symbol
OYST
Transactions as of
Dec 1, 2022
Transactions value $
-$36,490
Form type
4
Date filed
12/6/2022, 07:50 AM
Previous filing
Jul 8, 2022
Next filing
Jun 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OYST Common Stock Tax liability -$36.5K -3.26K -4.19% $11.20 74.5K Dec 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the non-reportable vesting and settlement of restricted stock units (the "RSUs"). Such RSUs were previously reported on the Reporting Person's Form 4 as to (i) 11,222 filed with the Securities and Exchange Commission on February 2, 2021 (the "2021 Award"); and (ii) 19,500 filed with the Securities and Exchange Commission on January 11, 2022 (the "2022 Award"). 2,805 RSUs of the 2021 Award and 4,875 RSUs of the 2022 Award were subsequently accelerated, effective December 1, 2022, resulting in the withholding being reported herein.